Literature DB >> 9324148

Direct hepatic vein anastomosis during hepatectomy for colorectal liver metastases.

S Nakamura1, S Suzuki, T Hachiya, H Ochiai, H Konno, S Baba.   

Abstract

BACKGROUND: When the right and middle hepatic veins (RHV and MHV) and all the short hepatic veins are removed during resection of segments (S) 7 and 8 and part of S 5 and 6 including the caudate lobe, the remainder of S 5 and 6 shows congestion, so restoration of liver function may be delayed.
METHODS: In 5 patients with hepatic metastases of colorectal carcinoma, which were in the region circumscribed by the RHV, MHV, and inferior vena cava, direct hepatic vein anastomosis was performed during hepatectomy.
RESULTS: Hepatic vein reconstruction took 17 to 30 minutes to complete. All 5 patients had an uneventful postoperative course, and the anastomosis was patent at 1 month after operation. One patient died of recurrent carcinoma 6 months after operation. Four have remained alive and disease free for 12, 24, 40, and 61 months.
CONCLUSION: Direct hepatic vein anastomosis is an option, which should be adopted in hepatectomy, especially in patients with carcinoma invading the major hepatic veins and short hepatic veins.

Entities:  

Mesh:

Year:  1997        PMID: 9324148     DOI: 10.1016/s0002-9610(97)00103-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Partial Hepatectomy with Middle Hepatic Vein Reconstruction Using a Left Inferior Vena Cava Graft.

Authors:  Yusuke Kawamoto; Yusuke Ome; Kazuyuki Kawamoto
Journal:  Case Rep Gastroenterol       Date:  2017-05-19

2.  Minor-but-Complex Liver Resection: An Alternative to Major Resections for Colorectal Liver Metastases Involving the Hepato-Caval Confluence.

Authors:  Lucio Urbani; Gianluca Masi; Marco Puccini; Piero Colombatto; Caterina Vivaldi; Riccardo Balestri; Antonio Marioni; Valerio Prosperi; Francesco Forfori; Gabriella Licitra; Chiara Leoni; Adriana Paolicchi; Piero Boraschi; Alessandro Lunardi; Carlo Tascini; Maura Castagna; Piero Buccianti
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.